Parkside Financial Bank & Trust’s Roivant Sciences ROIV Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.8M	Buy	1,329,164 +162,408	+14%	+$4.17M	2.82%	5
2025 Q4	$25.3M	Buy	1,166,756 +468,236	+67%	+$9.24M	1.89%	7
2025 Q3	$10.6M	Sell	698,520 -611,021	-47%	-$7.56M	0.82%	20
2025 Q2	$14.8M	Buy	1,309,541 +695,615	+113%	+$7.54M	1.59%	13
2025 Q1	$6.19M	Buy	613,926 +613,720	+297,922%	+$6.64M	0.79%	22
2024 Q4	$2.44K	Buy	206 +11	+6%	+$130	﹤0.01%	1593
2024 Q3	$2.25K	Hold	195	–	–	﹤0.01%	1575
2024 Q2	$2.06K	Hold	195	–	–	﹤0.01%	1548
2024 Q1	$2.06K	Hold	195	–	–	﹤0.01%	1507
2023 Q4	$2.19K	Hold	195	–	–	﹤0.01%	1486
2023 Q3	$2.28K	Hold	195	–	–	﹤0.01%	1626
2023 Q2	$1.97K	Hold	195	–	–	﹤0.01%	1690
2023 Q1	$1.44K	Buy	+195	New	+$1.61K	﹤0.01%	1780

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Parkside Financial Bank & Trust's ROIV Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Roivant Sciences (ROIV) stake by 14% in Q1 2026, buying an estimated $4.17M and bringing the position to 1,329,164 shares worth $36.8M. The position accounts for 2.82% of the portfolio, ranked #5.

Parkside Financial Bank & Trust first reported a position in ROIV in Q1 2023 and has held it in 13 quarters since. 444 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

Parkside Financial Bank & Trust held 1,329,164 shares of Roivant Sciences worth $36.8M as of Q1 2026.
Parkside Financial Bank & Trust bought 162,408 Roivant Sciences shares in Q1 2026, an estimated $4.17M.
Roivant Sciences made up 2.82% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #5 holding.
Parkside Financial Bank & Trust first reported a position in Roivant Sciences in Q1 2023 and has held it in 13 quarters since.
444 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.